Search

Heart Rhythm 2016, the Heart Rhythm Society’s (HRS) 37th Annual Scientific Sessions and this year’s leading conference on cardiac arrhythmias, commences at the Moscone Center. The meeting focuses on the importance of collaboration to propel the field of cardiac pacing and electrophysiology (EP) forward. HRS is the only organization that brings together the world’s leading clinicians, scientists and allied health professionals to help end death and suffering from heart rhythm disorders.

The Heart Rhythm Society (HRS) encourages and supports the efforts of early career electrophysiologists and other heart rhythm professionals to participate in the Society’s activities. To that end, the Heart Rhythm Travel Scholarships support participation in the Annual Scientific Sessions with a complimentary registration to Heart Rhythm, up to $1,500 in reimbursement of travel costs paid after the Annual Scientific Sessions, and award presentation at the Heart Rhythm Society VIP Reception.

Today, Heart Rhythm 2017, the Heart Rhythm Society’s (HRS) 38th Annual Scientific Sessions, kicks off at McCormick Place in Chicago where leading clinicians, scientists, researchers, educators and innovators from around the world present and discuss groundbreaking research for the care of cardiac arrhythmias. The theme of this year’s meeting is “Together We Can” to reinforce the importance of global collaboration to propel the field of electrophysiology (EP) forward. 

The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States on indications of patients who undergo magnetic resonance imaging (MRI) and radiation exposure with cardiovascular implantable electronic devices (CIEDs). The expert writing group presented the recommendations included in the 2017 HRS Expert Consensus Statement on Magnetic Resonance Imaging and Radiation Exposure in Patients with Cardiovascular Implantable Electronic Devices today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.  

A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in treating ventricular arrhythmias for pediatric patients who are at risk for sudden cardiac death (SCD). The study represents the largest pediatric patient population to date when evaluating the WCD as a therapy option. The findings of the study were presented today at Heart Rhythm 2017, the Heart Rhythm’s 38th Annual Scientific Sessions.

A new study shows that the Apple Watch's heart rate sensor, when paired with an artificial intelligence-based algorithm, can detect a serious and often symptomless heart arrhythmia, atrial fibrillation (AF). The new research uses a deep neural network based on photoplethysmographic (PPG) sensors commonly found in smart watches. The results of this study were presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.

Today, the Heart Rhythm Society (HRS) in joint partnership with the European Heart Rhythm Association (EHRA), European Cardiac Arrhythmia Society (ECAS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) issued an international consensus statement that provides a state-of-the-art review of the indications, techniques, and outcomes of catheter and surgical ablation of atrial fibrillation (AF). The 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, first issued in 2007, and again in 2012, represents a state-of-the art review of the field of catheter and surgical ablation of AF. This document is a complete and comprehensive revision of the 2012 statement and was presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.  

The Heart Rhythm Society (HRS) seeks to recognize and promote excellence in the field of cardiac pacing and electrophysiology. HRS offers a variety of awards and scholarships for heart rhythm professionals at every stage of their careers, from fellow-in-training to seasoned professional.

All Allied Professionals are automatically eligible for this award when submitting an abstract in the Allied Professionals category. Once the review process has been completed and all authors have been notified in February regarding the status of their abstracts, the winner of the Highest Scoring Abstract in the Allied Professionals Category award will be announced.

To be considered for this award, you must be a fellow currently in a training program or no more than one year out of fellowship training as of May 2017. You must also indicate your interest in applying for this award during the regular abstract submission period (October 7-December 2, 2016).  In late January, after abstracts have gone through the peer-review process, the submitting authors of the top five highest scoring abstracts will be sent an award application to complete, as along with an eligibility form to be signed by their training directors. Once the awards review process has been completed and all authors have been notified in February of the status of their abstracts, the winner of the award will be announced.

February 1, 2015 - The Heart Rhythm Society convened a forum of stakeholders in medical device innovation in conjunction with the 2015 Heart Rhythm Society Annual Scientific Sessions. The forum facilitated open discussion on medical device innovation, including obstacles to physician involvement and possible solutions. This report is based on the themes that emerged.